Nanalysis Scientific corporate update, Q2 2019 sales and board change
VANCOUVER, July 17, 2019 /CNW/ - Nanalysis Scientific Corp. (formerly Canvass Ventures Ltd.) ") (TSX Venture Exchange NSCI) (the "Exchange") is pleased to provide an inaugural post listing update and first official press release as a public company.
Nanalysis secures key strategic investor, Factors Group
Calgary, Alberta, June 10, 2019 - Nanalysis Scientific Corp. (the “Company” or “Nanalysis”, TSX Venture Exchange: NSCI), is pleased to announce it has closed a non-brokered private placement with the Chairman of Factors Group (the “Offering”).
Download the full news release
NANALYSIS SCIENTIFIC CORP. (FORMERLY CANVASS VENTURES LTD.) ANNOUNCES COMPLETION OF QUALIFYING TRANSACTION
June 4, 2019
VANCOUVER, BRITISH COLUMBIA, June 4, 2019 – Nanalysis Scientific Corp. (formerly Canvass Ventures Ltd.) is pleased to announce the completion of the previously-announced qualifying transaction under the policies of the TSX Venture Exchange (the “TSXV”).
Download the full press release
CANVASS VENTURES LTD. AND NANALYSIS CORP. ANNOUNCE TSXV CONDITIONAL APPROVAL AND FILING OF FILING STATEMENT
May 24, 2019
Canvass Ventures Ltd. has received conditional approval from the TSX Venture Exchange for its previously announced qualifying transaction (as defined under TSX-V Policy 2.4) with Nanalysis Corp., whereby Canvass will acquire all of the outstanding Class A common shares of Nanalysis by way of a three-corner amalgamation among Canvass, Nanalysis and 2176406 Alberta Ltd., a wholly owned subsidiary of Canvass. Pursuant to the transaction, Canvass will change its name to Nanalysis Scientific Corp.